Multiple sclerosis: recent advances in diagnosis clinical immunology and virology. 1977

D W Paty

UI MeSH Term Description Entries
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

D W Paty
August 1998, Current opinion in neurology,
D W Paty
February 2006, Revue neurologique,
D W Paty
October 1980, Journal of the Tennessee Medical Association,
D W Paty
September 1977, Pediatric research,
D W Paty
November 1972, The Medical clinics of North America,
D W Paty
April 1961, Armed Forces medical journal, India,
D W Paty
December 1959, Canadian journal of medical technology,
D W Paty
January 2018, International archives of allergy and immunology,
D W Paty
February 2021, Biomedical materials (Bristol, England),
D W Paty
April 1996, Australian and New Zealand journal of medicine,
Copied contents to your clipboard!